» Articles » PMID: 17163844

Expression of Transmembrane Carbonic Anhydrases IX and XII in Ovarian Tumours

Overview
Journal Histopathology
Date 2006 Dec 14
PMID 17163844
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Carbonic anhydrase (CA) isozymes IX and XII have been suggested to play a role in oncogenic processes. The aim of the present study was to investigate CA IX and XII expression in patients with ovarian tumours.

Methods And Results: A series of ovarian tumours was immunostained for CA IX and XII and the results were correlated with histopathological and clinical parameters. Most cases of borderline mucinous cystadenomas, mucinous cystadenocarcinomas and serous cystadenocarcinomas were moderately or strongly positive for CA IX. In malignant tumours, the staining was most prominent in hypoxic regions. Expression of CA XII was detected in all tumour categories, although the mean staining intensity was weaker than for CA IX in all groups except for clear cell carcinomas.

Conclusions: The wide expression of CA IX and XII in ovarian tumours suggests that these isozymes could represent potential targets in ovarian cancer therapy. The expression pattern of CA IX suggests that it could also serve as a useful histopathological marker protein for hypoxia in malignant ovarian tumours.

Citing Articles

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Braconi L, Riganti C, Parenti A, Cecchi M, Nocentini A, Bartolucci G Molecules. 2024; 29(14).

PMID: 39064868 PMC: 11279465. DOI: 10.3390/molecules29143290.


The relationship between nonsteroidal anti-inflammatory drugs and cancer incidence: An umbrella review.

Wang P, Chen B, Huang Y, Li J, Cao D, Chen Z Heliyon. 2024; 10(2):e23203.

PMID: 38312641 PMC: 10834481. DOI: 10.1016/j.heliyon.2023.e23203.


Multiple Regulatory Signals and Components in the Modulation of Bicarbonate Transporters.

Kim H, Hong J Pharmaceutics. 2024; 16(1).

PMID: 38258089 PMC: 10820580. DOI: 10.3390/pharmaceutics16010078.


Formation of morpholine-acetamide derivatives as potent anti-tumor drug candidates: Pharmacological evaluation and molecular docking studies.

Sheikh A, Altaf R, Nadeem H, Khan M, Murtaza B Heliyon. 2023; 9(11):e22183.

PMID: 38053851 PMC: 10694180. DOI: 10.1016/j.heliyon.2023.e22183.


Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors.

Sufian M, Zamanova S, Shabana A, Kemp B, Mondal U, Supuran C Int J Mol Sci. 2023; 24(5).

PMID: 36902027 PMC: 10002582. DOI: 10.3390/ijms24054595.